Prominex
Prominex is dedicated to transforming infectious disease testing by developing rapid, accurate, easy-to-use, affordable, reusable, multiplex, accessible, and scalable molecular diagnostic solutions. Founded in 2018, the company focuses on near-patient testing with results in 5 minutes, utilizing innovative technologies like dCliP. Their mission is to improve global access to rapid, accurate, and affordable infectious disease diagnostics, with a leadership team experienced in molecular diagnostics and medical devices. Prominex's products include the Prominex System and digital devices for infectious disease detection, with a strong emphasis on democratizing diagnostics and meeting WHO's ideal test characteristics.
Industries
Nr. of Employees
small (1-50)
Prominex
6181 Cornerstone Ct. E # 106, San Diego, CA 92121, USA
Patents
Products
5-minute molecular diagnostic OTC/POC digital device
A point-of-care/over-the-counter diagnostic system combining a nuclease-based molecular assay with a digital lateral-flow reader to deliver molecular-quality results in about 5 minutes.
5-minute molecular diagnostic OTC/POC digital device
A point-of-care/over-the-counter diagnostic system combining a nuclease-based molecular assay with a digital lateral-flow reader to deliver molecular-quality results in about 5 minutes.
Services
Development of molecular assays for respiratory and sexually transmitted infections, including assay design, analytical validation, and integration with a digital reader.
Design and development of reusable diagnostic readers and disposable assay cassettes engineered for scalability and high-volume production.
Development of molecular assays for respiratory and sexually transmitted infections, including assay design, analytical validation, and integration with a digital reader.
Design and development of reusable diagnostic readers and disposable assay cassettes engineered for scalability and high-volume production.
Expertise Areas
- Point-of-care and over-the-counter molecular diagnostics
- Assay development for infectious diseases (respiratory and STIs)
- Nuclease-based molecular chemistry development
- Digital lateral-flow detection and reader development
Key Technologies
- Nuclease-based isothermal amplification
- Duplex-specific nuclease (DSN) chemistry
- Digital lateral-flow colorimetric detection
- Surface-mediated reflectance photometry
News & Updates
A low-cost molecular diagnostic testing solution for infectious diseases that delivers lab-quality results in as little as 5 minutes, capable of detecting multiple pathogens and designed for accessibility.
Funding development of 5-minute point-of-care molecular diagnostics, raised from Casdin Capital LLC.
Funding development of 5-minute point-of-care molecular diagnostics, raised from Casdin Capital LLC and Paul Thomas.
Development of fully-automated multiplex molecular point-of-care testing that provides results in five minutes using novel amplification and detection technology.
A low-cost molecular diagnostic testing solution for infectious diseases that delivers lab-quality results in as little as 5 minutes, capable of detecting multiple pathogens and designed for accessibility.
Funding development of 5-minute point-of-care molecular diagnostics, raised from Casdin Capital LLC.
Funding development of 5-minute point-of-care molecular diagnostics, raised from Casdin Capital LLC and Paul Thomas.
Development of fully-automated multiplex molecular point-of-care testing that provides results in five minutes using novel amplification and detection technology.